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Abstract
Background: Type 2 diabetes mellitus (T2DM), an epidemic disease around world, has recently been identified as a
risk factor for osteoporosis-associated fracture. However, there is no consensus on the best method of assessing
fracture risk in patients with T2DM. The aim of this study was to evaluate the usefulness of the Osteoporosis Self-
Assessment Tool for Asians (OSTA) and the Singh Index (SI) in hip fracture risk assessment in patients with T2DM.
Methods: We enrolled 261 postmenopausal women with T2DM: 87 had hip fracture resulting from low-energy
trauma and 174 age-matched controls had no fracture (two controls per fracture case). Bone mineral density (BMD)
was measured with dual-energy X-ray absorptiometry in the lumbar spine and hip region. The SI was obtained
from standard antero-posterior radiographs of the pelvis. The OSTA was calculated with a formula based on weight
and age. Data were analyzed with descriptive statistics and tests of difference. Receiver operating characteristic
analysis was used to determine optimum cutoff values, sensitivity, and specificity of screening methods. Discriminative
abilities of different screening tools were compared with the area under the curve (AUC).
Results: There were significant differences in BMD at all sites (lumbar spine, femoral neck, trochanter, and total hip)
and in SI between the fracture and non-fracture groups (P < 0.05). There was no significant difference in OSTA between
the groups (P > 0.05). The area under the curve was 0.747 (95% CI: 0.680–0.813) for lumbar spine BMD, 0.699
(95% CI: 0.633–0.764) for total hip BMD, 0.659 (95% CI: 0.589–0.729) for femoral neck BMD, 0.631 (95% CI: 0.557–0.704)
for trochanter BMD, 0.534 (95% CI: 0.459–0.610) for OSTA, 0.636 (95% CI: 0.564–0.709) for SI, and 0.795 (95% CI:
0.734–0.857) for OSTA plus SI. The AUC for combined OSTA plus SI was significantly superior to other parameters
besides BMD of the lumbar spine.
Conclusions: The combination of OSTA plus SI could be a clinical alternative tool for screening of hip fracture risk in
large diabetic populations. These tests are inexpensive and simple to perform and could be especially useful in areas
where BMD measurement is not accessible.
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Background
Diabetes mellitus is an epidemic disease associated with
substantial comorbidity. The number of people with type
2 diabetes mellitus (T2DM) is expected to steadily in-
crease worldwide [1]. T2DM has recently been identified
as an important risk factor for osteoporosis-associated
fracture, depending on skeletal site and disease severity
[2–4]. Bone mineral density (BMD) by dual-energy X-
ray absorptiometry (DXA) is recognized as a major tool
to detect osteoporosis and predict fracture risk. How-
ever, because of the complex pathophysiology of T2DM,
BMD studies in diabetic patients have shown contradict-
ory results, including normal, reduced, and increased
BMD [5–8]. As a result of this controversy, there is no
consensus on the best method of assessing fracture risk
in patients with T2DM [9–11].
The Singh Index (SI) is a simple, semiquantitative
evaluation tool for diagnosing osteoporosis with plain ra-
diographs [12]. The SI is based on the trabecular pattern
of the proximal femur and classifies osteoporosis into six
grades. This method is available for routine use and
mass screening because plain films can be obtained at
most outpatient clinics. Several studies have confirmed
that the SI is an effective tool to assess proximal femoral
bone strength [13–15]. However, the reliability and ac-
curacy of the SI remain controversial compared with
BMD assessment. In addition, the SI was proposed to
contain independent information about osteoporosis,
which might reflect structural integrity in trabecular
bone [13, 16, 17]. Several studies have suggested that a
combination of reduced bone mass and altered bone
quality, which are not assessed with BMD alone, are
important risk factors for fracture in diabetic patients
[18, 19]. Therefore, SI may be used as a screening tool
to help clinicians identify patients at increased fracture
risk.
The Osteoporosis Self-Assessment Tool for Asians
(OSTA) has been developed to discriminate patients
with high osteoporosis risk for BMD measurement by
using a formula [20, 21]. In previous studies, the OSTA
has been shown to effectively predict osteoporosis risk
and to determine appropriate use of BMD testing in
Asian countries without sufficient DXA equipment
[22–25]. A few studies have also demonstrated that
OSTA may help to identify fracture risk among post-
menopausal women [26–28]. Based on a study in
eight Asian countries, the OSTA index uses only age
and weight from among 11 risk factors to classify the
risk of osteoporosis [29]. Because T2DM is associated
with increased body weight, the OSTA may underesti-
mate fracture risk in diabetic patients and its validity
in these patients remains unknown.
With current demographic changes, physicians will
need to treat an increasing number of diabetic patients
at a higher risk of osteoporosis. Hip fracture is the most
devastating consequence of osteoporosis, with high mor-
bidity, mortality, and economic burden. However, DXA
scans are not available to evaluate bone health at all
healthcare centers because this diagnostic method is ex-
pensive and complicated. Thus, clinicians need a simple
and inexpensive screening method to discriminate those
patients at high risk of hip fracture from among the
large number of patients with diabetes. In the present
analysis, we investigated the discriminative ability of
OSTA and SI alone and in combination in predicting
hip fracture risk in T2DM patients. We sought an alter-
native method of identifying those diabetic patients at
risk for hip fracture in daily clinical practice.
Methods
This retrospective study was conducted at a single uni-
versity teaching center. Postmenopausal women with
T2DM and femoral neck or intertrochanteric fracture
resulting from low-energy trauma were retrospectively
recruited from 2009 to 2015. Patients who had under-
gone BMD measurement of the spine and of the hip
contralateral to the fracture site at the time of fracture
were eligible for inclusion. Control cases were selected
from our pool of patients with BMD testing results and
medical records. For every patient with hip fracture, we
included two matched controls with T2DM, age ± 2 years,
and no low-energy fracture. Exclusion criteria for all par-
ticipants were the following: (1) any treatment or illness
that would affect bone metabolism, (2) history of any
spinal surgery, and (3) severe scoliosis or degenerative
lumbar disease that would affect BMD measurement.
In all cases, T2DM was diagnosed on the basis of med-
ical records and questionnaire. If a diabetes diagnosis
was made during the 5 years prior to BMD testing, the
T2DM status was confirmed. Body mass index (BMI)
was calculated with the following standard formula:
BMI = weight (kg)/height (m)2.
BMD measurements
BMD testing was performed with a single DXA scanner
(Discovery W; Hologic, Inc., Bedford, MA, USA). An
anatomical spine phantom was measured daily for
quality control at our institution. The coefficient of
variation of the technique was 0.8%, indicating stable
results. Every participant had BMD measured at the
left hip and at the lumbar spine from L1 to L4. In
patients with hip fracture, BMD was measured on the
contralateral hip. All BMD measurements were made
by two experienced technicians. The scanning proce-
dures and analysis were performed according to the
standard manual supplied by the manufacturer. BMD
was calculated on the basis of normal reference values for
the Chinese population, in accordance with manufacturer
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recommendations. T-scores were used to express BMD.
BMD was classified based on the World Health
Organization criteria: T-score ≤−2.5 SD, osteoporotic;
T-score >−2.5 and <−1.0 SD, osteopenic; T-score ≥−1.0,
normal.
OSTA calculation
The OSTA index was calculated with the following for-
mula: [body weight (kg) − age (years)] × 0.2. Digits after
the decimal point were disregarded. The OSTA values
were classified as follows: <−4, high risk; −4 to −1, inter-
mediate risk; >−1, low risk.
Evaluation of the Singh Index
Standard digital antero-posterior radiographs of the pel-
vis in the supine position were obtained to assess the SI.
According to the Singh criteria, SI scores ranged from 1
(severe osteoporosis) to 6 (normal bone density). SI was
assessed in the proximal femur on the same side used
for BMD measurement. All radiographs were evaluated
by a single observer.
The following parameters were collected for each par-
ticipant: patient age, weight, height, BMI, fracture site,
BMD, OSTA, and SI.
Statistical analysis
Statistical analyses were performed with SSPS software
18.0 (SPSS, Chicago, IL, USA). Descriptive statistics are
expressed as mean ± standard deviation (SD). Intergroup
differences were assessed with Student’s t test or analysis
of covariances when adjusted for confounding factors,
depending on the distribution normality of the tested
parameter. P values <0.05 were considered statistically
significant. The diagnostic value of each parameter was
evaluated with the area under the receiving operator curve
(ROC; AUC: area under the curve). Ninety-five percent
confidence intervals of the AUC were calculated.
Results
The final study population included 261 women, 87 with
hip fracture and 174 controls without hip fracture. In
the hip fracture group, 66.7% (58/87) had a T-score
lower than −2.5 SD; in the control group, only 41.4%
(72/174) had a T-score lower than −2.5 SD. Descriptive
statistics of the study population are presented in
Table 1.
Comparison between participants with and without
fracture
There were no significant differences between the fracture
and non-fracture groups in mean age (74.0 vs. 73.9 years,
P = 0.879), height (157.1 vs. 156.5 cm, P = 0.897), weight
(60.8 vs. 62.4 kg, P = 0.135), BMI (24.7 vs. 25.5 kg/cm2,
P = 0.103), or OSTA scores (−2.3 vs. −2.0, P = 0.208).
All BMD parameters at the lumbar spine and hip re-
gion (including total hip, femoral neck, and trochanter
regions) were notably lower in the fracture group than
in the non-fracture group, (−2.2 vs. −1.2, P < 0.0001 for
lumbar spine; −2.6 vs. −1.6, P < 0.0001 for total hip;
−2.7 vs. −2.0, P < 0.0001 for femoral neck; −2.3 vs. −1.6,
P < 0.0001 for trochanter). In addition, SI scores were
lower in the fracture group than in the non-fracture
group (3.4 vs. 3.7, P = 0.017). All BMD parameters and
SI scores remained significantly different when adjusted
for BMI with covariance. Results are presented in
Table 1.
ROC curve
With regard to hip fracture, the screening test perform-
ance characteristics and ROC curves are shown in
Table 2 and Fig. 1. The AUC was 0.534 (95% CI: 0.459–
0.610) for the OSTA, 0.636 (95% CI: 0.564–0.709) for
the SI, 0.747 (95% CI: 0.680–0.813) for lumbar spine
BMD, 0.699 (95% CI: 0.633–0.764) for total hip BMD,
0.659 (95% CI: 0.589–0.729) for femoral neck BMD, and
Table 1 Characteristics of patients with fracture in comparison to those without fracture
Subjects with fracture(n = 87) Control subjects(n = 174) P value
Mean (range) SD Mean (range) SD
Age (years) 74.0(56~86) 6.6 73.9(56~85) 6.2 0.879
Height (cm) 157.1(143.8~175.0) 5.9 156.5(143.1~170.3) 4.6 0.371
Weight (kg) 60.8(36.1~80.9) 8.4 62.4(43.8~81.0) 8.0 0.147
BMI 24.7(11.9~35.6) 4.0 25.5(17.3~36.5) 3.6 0.103
Lumbar spine T-score −2.2(−4.3~0.8) 1.1 −1.2(−3.3~2.2) 0.9 <0.001
Total hip T-score −2.6(−4.9~1.3) 1.3 −1.6(−4.4~1.8) 1.4 <0.001
Femoral neck T-score −2.7(−4.9~2.9) 1.4 −2.0(−4.4~1.8) 1.2 <0.001
Femoral trochanter T-score −2.3(−5.1~0.6) 1.4 −1.6(−4.4~2.3) 1.3 <0.001
OSTA score −2.2(−7~2) 1.7 −2.0(−6~3) 1.8 0.215
Singh index 2.9(1~6) 1.3 3.5(1~6) 1.2 <0.001
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0.631 (95% CI: 0.557–0.704) for trochanter BMD. The
cutoffs were −2.5, 2.5, −1.85, −2.45, −2.05, and −2.25, re-
spectively. Furthermore, the optimal cutoff point as de-
fined with the Youden index (sensitivity + specificity − 1)
yielded the maximum value. AUCs of these parameters
from high to low were BMD (lumbar spine), BMD (total
hip), BMD (trochanter), SI, BMD (femoral neck), and
OSTA. Next, the OSTA plus SI combination model was
obtained using a logistic regression process. The AUC of
the combination of OSTA plus SI was 0.795 (95% CI:
0.734–0.857). The combination of OSTA plus SI was
compared with other screening methods. The AUC for
combined OSTA plus SI was significantly different from
that of OSTA alone (95% CI: 0.173–0.349, Z = 5.817,
P < 0.0001), SI alone (95% CI: 0.086–0.232, Z = 4.254,
P < 0.0001), BMD of total hip (95% CI: 0.017–0.177,
Z = 2.368, P = 0.0179), BMD of trochanter (95% CI:
0.084–0.246, Z = 3.982, P = 0.0001), and BMD of fem-
oral neck (95% CI: 0.086–0.232, Z = 4.254, P < 0.0001).
However, the combination was not significantly super-
ior to BMD of the lumbar spine (95% CI: −0.027–
0.125, Z = 1.258, P = 0.2084).
Discussion
In this study, we evaluated the potential predictive value
of the SI, OSTA, and of the combination of SI and
OSTA in differentiating diabetic women with hip frac-
ture from those without hip fracture. We found that the
combination of SI plus OSTA and BMD of the lumbar
spine performed better than SI alone, OSTA alone,
BMD of the femoral neck, and BMD of the trochanter.
The most noticeable result is that the combination of SI
Table 2 ROC analysis of diagnostic performance characteristics of BMD, OSTA, and SI




Lumbar spine T-score 0.747 0.680~0.813 −1.85 60.9 77 2.38 0.49
Total hip T-score 0.699 0.633~0.764 −2.45 52.9 71.8 1.71 0.67
Femoral neck T-score 0.659 0.589~0.729 −2.05 74.7 47.1 1.40 0.49
Femoral trochanter T-score 0.631 0.557~0.704 −2.25 50.6 69.5 1.53 0.73
OSTA score 0.534 0.459~0.610 −2.5 44.8 73.8 1.24 0.86
Singh index 0.636 0.564~0.709 2.5 42.5 88.2 1.95 0.74
Fig. 1 The ROC curves for BMD
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plus OSTA may be of clinical benefit when distinguish-
ing between diabetic women with hip fracture versus
without hip fracture. To be widely useful for a large
population with T2DM, an assessment tool must be as
simple as possible. The SI and OSTA are both simple,
quick, and inexpensive risk assessment tools. The com-
bination of SI plus OSTA could be especially useful in
communities where DXA is costly and inaccessible.
BMD is widely used to determine bone mass and frac-
ture risk in patients with risk factors for osteoporotic
fractures. However, previous studies have reported con-
flicting data on BMD and the risk of osteoporosis in pa-
tients with T2DM [30]. In the current study, we showed
that all BMD parameters were lower in patients with
fracture than in those without fracture. The prevalence
of osteoporosis was 66.7% in the fracture group and
41.4% in the control group, which also showed that
osteoporosis was high in prevalence in the subjects with
hip fracture. However, based on AUC analysis, BMD in
the lumbar spine was superior to BMD in other regions
in predicting hip fracture. BMD only explains 70 to 75%
of the variance in bone strength; the macrogeometry of
cortical bone and the microarchitecture of trabecular
bone may be responsible for much of bone strength
[31–35]. For a given BMD, diabetic bone is more fragile
and has a higher risk of fracture than non-diabetic bone
[36–38]. Some studies have indicated that material
changes and structural abnormalities lead to increased
bone fragility in patients with diabetes [39–41]. The
World Health Organization’s Fracture Risk Assessment
Tool, which is designed to predict the 10-year probabil-
ity of osteoporotic fracture based on femoral neck BMD
and other clinical risk factors, has been shown to under-
estimate fracture risk in diabetic patients. Hence, T2DM
presents specific challenges for fracture risk assessment.
Because it is expensive and time consuming, DXA is
not available at every healthcare center. The SI is a sim-
ple method of assessing bone strength that can be used
to assess osteoporosis without DXA. Previous studies
have shown that SI provides a reliable estimate of mech-
anical bone quality in addition to bone mass of the prox-
imal femur [42–44]. In another study, Cemal et al.
reported that the SI had relatively high specificity in pre-
dicting osteoporosis, but results were not consistent with
those obtained with DXA because only bone loss beyond
30 to 50% can be present on plain radiographs [45]. In
the present study, we adopted the Youden index to se-
lect an optimal cutoff threshold, which considered the
balance between both sensitivity and specificity. The
good performance is generally confirmed as AUC > 0.75.
The best cutoff of OSTA and SI for predicting hip frac-
ture were −2.5 and 2.5, respectively. It indicated further
attention needed for high fracture risk. This study sug-
gested that SI has a low predictive value (AUC 0.636)
and sensitivity (42.5%), but good specificity (88.2%) in
identifying hip fracture. SI alone was not an excellent
predictive tool. Although the SI has shortcomings, it
does have several advantages because it has good corre-
lations with mechanical parameters of the trabecular
bone of the proximal femur. In this study, we also evalu-
ated the performance of the OSTA and found that the
OSTA alone did not perform well in patients with dia-
betes. There was no significant difference in OSTA
scores between the fracture group and control group.
ROC analysis showed that the OSTA had a low predict-
ive value (AUC 0.534, sensitivity 44.8%, specificity 73.8%,
Fig. 2). Because the OSTA uses only age and weight as
risk factors in its calculation, it can be distorted by obes-
ity, which is widespread in T2DM. Overweight and obes-
ity are generally believed to be protective factors for
BMD through mechanical loading and hormonal factors,
including insulin, estrogen, and leptin [46, 47]. There-
fore, the OSTA index did not perform very well in iden-
tifying hip fracture in women with T2DM.
The present study provides further evidence about the
combined use of the OSTA plus SI in assessing fracture
risk in patients with T2DM. The data confirmed that the
combination of the OSTA plus SI had a high predictive
value (AUC 0.795), which was significantly higher than
other screening tools. Combining these two assessments
clearly enhanced their predictive ability. The findings
highlight the importance of incorporating both OSTA
and SI scores. However, the risk factors for hip fracture
are complicated in patients with diabetes. For example,
patients with T2DM are more likely to fall, but little is
known about the specific risk factors for falling, includ-
ing impaired visual acuity from diabetic retinopathy,
balance disorders from coexisting sensory motor neur-
opathy, and diabetic foot [48]. On the other hand,
T2MD may affect bone metabolism. As a result of con-
current albuminuria or exaggerated renal excretion of
vitamin D metabolites, the vitamin D insufficiency has
been linked to patients with diabetes compared to the
general population [49]. Biochemical markers of bone
metabolism, such as serum C-terminal telopeptide of
type I collagen (β-CTX) and serum N-amino terminal
prepeptide of type 1 procollagen (P1NP) have been
found to be associated with skeletal health in T2MD
[7, 30]. At the same time, there remained many con-
troversies regarding the underlying mechanisms for
bone fragility affected by diabetes metabolism. There-
fore, an assessment tool for hip fracture risk must be
further developed for the diabetic population.
The major limitation of this study is that was a retro-
spective case-control study. Prospective studies are more
appropriate for the prediction of incident fractures. Our
results cannot directly confirm an association between
the value of various parameters and osteoporotic hip
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fracture. However, we believe that this limitation had lit-
tle effect on the results. Second, the sample size was
relatively small and without random control. These char-
acteristics could have affected the spread of the data,
which should be further confirmed in other larger co-
horts. Furthermore, the OSTA was developed particu-
larly in Asian countries. This tool may need to be
validated in other ethnics.
Conclusions
The combination of the OSTA plus SI could be useful
for the clinical evaluation of hip fracture risk in
women with T2DM, despite the paradox of fracture
risk factors in this population. Considering that the
OSTA and SI are the briefest and least expensive ap-
proaches to assessing bone health, a combination of
the OSTA plus SI is suitable as a simple predictive
tool in clinical practice to screen for hip fracture risk
in a large diabetic population.
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